Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
TVRD
$1.02
+2.82%
TVRD
· Tvardi Therapeutics, Inc.
$1.02
+0.03 (+2.82%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, the Company has concluded that management's plans do not alleviate substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$13.87M
Shares
13.34M
Volume · Oct 21
137.1K
Avg daily vol (3M)
242.64K
All webcasts
Earnings call · FY2022 Q4
Tvardi Therapeutics, Inc. (TVRD) Q4 2022 Earnings Call
Revenue · derived Q4
$3.26M
Net income · derived Q4
-$30.34M
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 6, 2023 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 6, 2023 · complete as-filed document